Have to agree peace, the thing I love with this company is that no one drug trial failure can really bring it down, unless it somehow proves the technology to be faulty. I was following poh and Ado both to a degree As they seemed to be in a similar position but even they have the one item or technology, so ultimately if it fails they are stuck. If one drug/ peptide combo fails here theoretically the remaining library is still open for success with a totally different drug or application. Like everything it needs it's first success to get the floodgates open. Have they actually had a documented success with the technology as yet, or is it all just promising research?? Don't know the company well enough to know the full history without a lot of reading unfortunately.
PYC Price at posting:
7.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)